Analysis of mortality from COVID-19 in the Atyrau Region during the outbreak in 2020
https://doi.org/10.35627/2219-5238/2022-30-3-18-23
Abstract
Introduction: Among the population of the regions of Kazakhstan, deaths from COVID-19 were more frequent in the regions with high incidence rates. One of these regions was the Atyrau Region, which ranked fifth in the number of the infected in the republic in June 2020.
Objective: To analyze deaths from COVID-19 in the Atyrau Region during the outbreak in 2020.
Materials and methods: We analyzed medical histories of 53 inpatients who died of SARS-CoV-2 infection from June 1 to July 31, 2020 in the Atyrau Region.
Results: The main factors contributing to the lethal outcome included concomitant diseases, such as ischemic heart disease, diabetes mellitus, arterial hypertension, and obesity, which were diagnozed in 37 patients. The mortality rate was higher in elderly cases aged 61–70 years.
Discussion: Arterial hypertension was found to be the most prevalent comorbidity that worsened disease severity in COVID-19. Our study demonstrated that the relationship between hypertension and mortality in patients with the novel coronavirus disease largely reflected their elderly age.
Conclusions: The mortality data in the Atyrau Region showed deaths from COVID-19 during the period of high incidence of the disease in the summer of 2020 (6,069 cases were registered only in July 2020) potentially attributed to comorbidies, elderly age, delays in seeking medical help, a severe course of the disease with > 50 % lung involvement, lack of observation and outpatient treatment at the level of primary health care.
About the Authors
A. S. Sagatkali
West Kazakhstan Medical University named after Marat Ospanov
Kazakhstan
Kazakhstan
Aigerim S. Sagatkali, 2nd year undergraduate student specializing in preventive medicine, Department of Epidemiology
68 Marеsyev Street, Aktobe, 030019
K. Sh. Tussupkaliyeva
West Kazakhstan Medical University named after Marat Ospanov
Kazakhstan
Kazakhstan
Kymbat Sh. Tussupkaliyeva, Cand. Sci. (Med.), Associate Professor of the Department of Epidemiology
68 Marеsyev Street, Aktobe, 030019
S. T. Urazaуeva
West Kazakhstan Medical University named after Marat Ospanov
Kazakhstan
Kazakhstan
Saltanat T. Urazaуeva, Cand. Sci. (Med.), Associate Professor, Head of the Department of Epidemiology
68 Marеsyev Street, Aktobe, 030019
A. B. Urazayeva
West Kazakhstan Medical University named after Marat Ospanov
Kazakhstan
Kazakhstan
Aisha B. Urazayeva, M. Sci. (Med.), Senior lecturer, Department of Epidemiology
68 Marеsyev Street, Aktobe, 030019
References
1. Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J Infect. 2020;80(6):e14-e18. doi: 10.1016/j.jinf.2020.03.005
2. Zhu T, Wang Y, Zhou S, Zhang N, Xia L. A comparative study of chest computed tomography features in young and older adults with corona virus disease (COVID-19). J Thorac Imaging. 2020;35(4):W97-W101. doi: 10.1097/RTI.0000000000000513
3. Chen T, Dai Z, Mo P, et al. Clinical Characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China: A single-centered, retrospective Study. J Gerontol A Biol Sci Med Sci. 2020;75(9):1788-1795. doi: 10.1093/gerona/glaa089
4. Venediktova AA, Saperkin NV, Deryabina OI. Clinical and epidemiological characteristics of patients recovered from COVID-19 in the Nizhny Novgorod region. MediАl’. 2020;(2(26)):6-9. doi: 10.21145/2225-0026-2020-2-6-9
5. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) - China, 2020. China CDC Wkly. 2020;2(8):113-122.
6. Deng G, Yin M, Chen X, Zeng F. Clinical determinants for fatality of 44,672 patients with COVID-19. Crit Care. 2020;24(1):179. doi: 10.1186/s13054-020-02902-w
7. Pourfarzi F, Rahim Pouran S, Dargahi A, et al. The healthy behaviours and COVID-19 mortality among Iranian women: a case-control study. BMC Womens Health. 2021;21(1):366. doi: 10.1186/s12905-021-01512-0
8. Malik YS, Kumar N, Sircar S, et al. Coronavirus disease pandemic (COVID-19): challenges and a global perspective. Pathogens. 2020;9(7):519. doi: 10.3390/pathogens9070519
9. Klok FA, Kruip MJHA, van der Meer NJM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb Res. 2020;191:148-150. doi: 10.1016/j.thromres.2020.04.041
10. Pedreañez A, Mosquera-Sulbaran J, Muñoz N. SARSCoV-2 infection represents a high risk for the elderly: analysis of pathogenesis. Arch Virol. 2021;166(6):1565-1574. doi: 10.1007/s00705-021-05042-w
11. Lithander FE, Neumann S, Tenison E, et al. COVID-19 in older people: a rapid clinical review. Age Ageing. 2020;49(4):501-515. doi: 10.1093/ageing/afaa093
12. Tanaka K, Zha L, Kitamura T, et al; COVID-19 Epidemiology Research Group of Osaka University. Characteristics and outcomes of older patients with coronavirus disease 2019 in Japan. Geriatr Gerontol Int. 2021;21(8):629-635. doi: 10.1111/ggi.14207
13. Nikpouraghdam M, Jalali Farahani A, Alishiri G, et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. J Clin Virol. 2020;127:104378. doi: 10.1016/j.jcv.2020.104378
14. Covino M, De Matteis G, Santoro M, et al. Clinical characteristics and prognostic factors in COVID-19 patients aged ≥80years. Geriatr Gerontol Int. 2020;20(7):704-708. doi: 10.1111/ggi.13960
15. Deng X, Yang J, Wang W, et al. Case fatality risk of the first pandemic wave of coronavirus disease 2019 (COVID-19) in China. Clin Infect Dis. 2021;73(1):e79-e85. doi: 10.1093/cid/ciaa578
16. Kravchuk EN, Neimark AE, Babenko AYu, Grineva EN. Obesity and COVID-19. Arterial’naya Gipertenziya. 2020;26(4):440-446. (In Russ.) doi: 10.18705/1607-419X-2020-26-4-440-446
17. Noor FM, Islam MM. Prevalence and associated risk factors of mortality among COVID-19 patients: A meta-analysis. J Community Health. 2020;45(6):1270-1282. doi: 10.1007/s10900-020-00920-x
18. Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and Cardiovascular Disease. Circulation. 2020;141(20):1648-1655. doi: 10.1161/CIRCULATIONAHA.120.046941
19. Borch KH, Nyegaard C, Hansen JB, et al. Joint effects of obesity and body height on the risk of venous thromboembolism: the Tromsø Study. Arterioscler Thromb Vasc Biol. 2011;31(6):1439-1444. doi: 10.1161/ATVBAHA.110.218925
20. Freeman AL, Pendleton RC, Rondina MT. Prevention of venous thromboembolism in obesity. Expert Rev Cardiovasc Ther. 2010;8(12):1711-1721. doi: 10.1586/erc.10.160
21. Morris SB, Schwartz NG, Patel P, et al. Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection – United Kingdom and United States, March–August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(40):1450-1456. doi: 10.15585/mmwr.mm6940e1
22. Ivanov MA, Agurbash AN. The realities of predicting the development of COVID-19 complications. Profilakticheskaya i Klinicheskaya Meditsina. 2021;(2(79)):77-81. doi: 10.47843/2074-9120_2021_2_77
23. Aghagoli G, Gallo Marin B, Soliman LB, Sellke FW. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review. J Card Surg. 2020;35(6):1302-1305. doi: 10.1111/jocs.14538
24. Lodigiani C, Iapichino G, Carenzo L, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020;191:9-14. doi: 10.1016/j.thromres.2020.04.024
Review
For citations:
Sagatkali A.S., Tussupkaliyeva K.Sh., Urazaуeva S.T., Urazayeva A.B. Analysis of mortality from COVID-19 in the Atyrau Region during the outbreak in 2020. Public Health and Life Environment – PH&LE. 2022;(3):18-23. (In Russ.) https://doi.org/10.35627/2219-5238/2022-30-3-18-23
Views:
319
.png)
Email this article 